Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-69019-6
Abstract: While the patency of vascular access is essential for hemodialysis patients, optimal pharmaceutical treatment to maintain arteriovenous fistula (AVF) patency remains lacking. As cardiovascular diseases are highly prevalent in patients with end-stage renal disease, various… read more here.
Keywords: patency; antiplatelet; cardiovascular medications; group ... See more keywords